Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Daily News

New US Valve Guidance Tackles TAVR vs TAVI, Low-risk AS, Functional MR

Caitlin E. Cox

December 23, 2020

News Conference News TCT 2020

Acurate Neo Still Falls Short of Sapien 3 in SCOPE 1-Year Follow-up

Michael O'Riordan

October 23, 2020

News Conference News TCT 2020

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

Michael O'Riordan

October 15, 2020

Presentation TCT 2020

TCT 469: Paravalvular Aortic Regurgitation After TAVI. Aortography, Echocardiography and Hemodynamic Assessment in Relation to Survival

Presenter: Gabor Dekany

October 14, 2020

News Daily News

PARTNER Data Back 5-Year Durability of Sapien 3 TAVR

Caitlin E. Cox

October 12, 2020

News Daily News

TAVR and Infective Endocarditis—Two Studies Address a Shifting Landscape

Caitlin E. Cox

September 14, 2020

News Daily News

Which TAVR Device Is Best? Review Tackles Optimal Selection

Michael O'Riordan

September 09, 2020

News Conference News ESC 2020

Implantation Technique Influences LV Remodeling After TMVR

Todd Neale

September 04, 2020

News Daily News

Should Guidelines Support TAVR for Low-Risk Patients? Two Views

L.A. McKeown

August 17, 2020

News Daily News

Next-Day Discharge Safe After Uncomplicated Transfemoral TAVR

Todd Neale

August 12, 2020

News Conference News TVT 2020

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

Michael O'Riordan

June 22, 2020

Presentation TVT 2020

Real-world experience with the SAPIEN 3 Ultra TAVR: A propensity matched analysis from the United States

Presenter: Tamim Nazif

June 20, 2020

News Conference News TVT 2020

Newer TAVR Devices Reassure in Failed Surgical Valves

Shelley Wood

June 20, 2020

News Conference News TVT 2020

Skipping Predilatation in Low-risk TAVR Patients Does Not Mar Outcomes

L.A. McKeown

June 19, 2020

News Daily News

June 2020 News Roundup

L.A. McKeown

June 01, 2020

News Conference News SCAI 2020

Late and Early Results in Tune for Melody and Harmony Transcatheter PVs

Caitlin E. Cox

May 25, 2020

News Daily News

LV Mass Regression After TAVR Linked to Better Long-term Outcomes

Michael O'Riordan

May 13, 2020

News Conference News ACC 2020

PARTNER 3: TAVR Now Noninferior to Surgery at 2 Years in Low-Risk Patients

Yael L. Maxwell

March 29, 2020

Advertisement

New US Valve Guidance Tackles TAVR vs TAVI, Low-risk AS, Functional MR

Acurate Neo Still Falls Short of Sapien 3 in SCOPE 1-Year Follow-up

Acurate Neo Fails to Match Results of CoreValve Evolut: SCOPE 2

TCT 469: Paravalvular Aortic Regurgitation After TAVI. Aortography, Echocardiography and Hemodynamic Assessment in Relation to Survival

PARTNER Data Back 5-Year Durability of Sapien 3 TAVR

TAVR and Infective Endocarditis—Two Studies Address a Shifting Landscape

Which TAVR Device Is Best? Review Tackles Optimal Selection

Implantation Technique Influences LV Remodeling After TMVR

Should Guidelines Support TAVR for Low-Risk Patients? Two Views

Next-Day Discharge Safe After Uncomplicated Transfemoral TAVR

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

Real-world experience with the SAPIEN 3 Ultra TAVR: A propensity matched analysis from the United States

Newer TAVR Devices Reassure in Failed Surgical Valves

Skipping Predilatation in Low-risk TAVR Patients Does Not Mar Outcomes

June 2020 News Roundup

Late and Early Results in Tune for Melody and Harmony Transcatheter PVs

LV Mass Regression After TAVR Linked to Better Long-term Outcomes

PARTNER 3: TAVR Now Noninferior to Surgery at 2 Years in Low-Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content